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BACKGROUND The coronary sinus (CS) Reducer is a recently intro-
duced device to treat patients with severe anginal symptoms who are
refractory to optimal medical therapy and not amenable for conven-
tional revascularization. We aimed to assess the safety and efﬁcacy of
the CS Reducer in a “real world” cohort of patients with refractory
angina.
METHODS This is a single center retrospective registry. Patients with
severe anginal symptoms, objective evidence of myocardial ischemia
using any modality and without options for conventional revascu-
larization were regarded eligible for CS Reducer implantation.
RESULTS Twenty-three patients (74.0% male, mean age 708
years) underwent CS Reducer implantation (91.0% previous bypass
surgery, 48.0% previous myocardial infarction, 83.0% previous
percutaneous intervention, 52.0% diabetes mellitus). The safety
endpoint (successful delivery and deployment) was met in all pa-
tients. One patient suffered a procedure-related access site
complication (neck hematoma), which was treated conservatively.
After a median follow-up of 9 [8-14] months the efﬁcacy endpoint
(any reduction in Canadian Cardiovascular Society (CCS) class with
revascularization free survival) was reached in 17 patients (74.0%).
The majority of patients (78.3%) experienced an improvement of
clinical symptoms: 8 (34.8%) by 1 CCS class, 8 (34.8%) by 2 CCS
classes (1 of them underwent a revascularization at follow up) and 2
(8.7%) by 3 CCS classes. One patient died 4 month after implanta-
tion because of progressive heart failure (no association with the CS
Reducer implantation).
CONCLUSIONS In this single center ’real-world’ experience, the CS
Reducer implantation was safe and demonstrated clinical efﬁcacy in
the treatment of refractory angina at mid-term follow-up.CATEGORIES STRUCTURAL: Heart Failure
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BACKGROUND Although fractional ﬂow reserve (FFR) is the gold
standard in functional assessment of intermediate coronary stenosis,
it lacks anatomical information essential for risk stratiﬁcation of pla-
que and guidance of PCI. In IVUS, integrated backscatter (IB) values of
blood speckles, calculated as the average power of backscattered
radiofrequency (RF) signals from blood, have been shown to change as
a function of blood ﬂow velocity. This study aimed to investigate
potential utility of RF-IVUS for assessment of functional signiﬁcance
of intermediate coronary stenosis.
METHODS In 42 patients with intermediate lesions in 1 epicardial
coronary arteries, 45 arteries (28 left anterior descending; 3 left
circumﬂex; 14 right coronary artery) were evaluated by IB-IVUS and
intracoronary pressure measurements. Average IB values of blood
speckles within the lumen were measured at proximal (a segment
near the oriﬁce of the artery) and distal (a disease-free segment
>10 mm distal to the tightest site) segments to the lesion. As IB is a
logarithmic variable, a ratio of the distal and proximal IB values was
calculated as DIB between the 2 sites. As control, FFR during hyper-
emia and instantaneous wave-free ratio (iFR) were obtained using a
coronary pressure wire.
RESULTS Overall, the minimum lumen area (MLA) of the lesions
ranged from 1.0 to 7.4 mm2 (median 2.1 mm2). DIB signiﬁcantly
correlated with both FFR and iFR (Figure), which was also conﬁrmed
in a subset of lesions with small MLA (deﬁned as < the median value).
Receiver operating characteristic (ROC) curve analyses identiﬁed the
best cut-off value as 7.25 of DIB for predicting FFR 0.8 (sensitivity
100%; speciﬁcity 88%; positive predictive value 86%; negative
predictive value 100%, accuracy 93%), and 9.14 of DIB for predicting
iFR 0.89 (sensitivity 100%; speciﬁcity 79%; positive predictive
value 61%; negative predictive value 100%; accuracy 84%).
